This PDF is the current document as it appeared on Public Inspection on 04/28/2014 at 08:45 am.
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Center for Advancing Translational Sciences Special Emphasis Panel; RDCRN Data Management and Coordinating Center.
Date: May 7, 2014.
Date: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: Hilton Washington/Rockville, 1750 Rockville Pike, Rockville, MD 20852.
Contact Person: Guo He Zhang, Ph.D., MPH, Scientific Review Officer, Office of Grants Management and Scientific Review, National Center for Advancing Translational Sciences (NCATS); National Institutes of Health, 6701 Democracy Blvd., Democracy 1, Room 1064, Bethesda, MD 20892-4874, 301-435-0812, firstname.lastname@example.org.
This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle.Start Signature
Dated: April 22, 2014.
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-09618 Filed 4-28-14; 8:45 am]
BILLING CODE 4140-01-P